Assessing neurotoxicity of drugs of abuse:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Rockville, MD
National Inst. on Drug Abuse
1993
|
| Schriftenreihe: | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series
136 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | VI, 281 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV009127565 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 940314s1993 d||| |||| 00||| engod | ||
| 035 | |a (OCoLC)29307989 | ||
| 035 | |a (DE-599)BVBBV009127565 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 050 | 0 | |a RC347.5 | |
| 050 | 0 | |a RM316 | |
| 082 | 0 | |a 615/.78 |2 20 | |
| 245 | 1 | 0 | |a Assessing neurotoxicity of drugs of abuse |c ed.: Lynda Erinoff |
| 264 | 1 | |a Rockville, MD |b National Inst. on Drug Abuse |c 1993 | |
| 300 | |a VI, 281 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |v 136 | |
| 650 | 4 | |a Central Nervous System Agents |x toxicity | |
| 650 | 4 | |a Central Nervous System |x drug effects | |
| 650 | 4 | |a Drug abuse |x Health aspects |x Research |z United States |v Congresses | |
| 650 | 4 | |a Neuropharmacology |x Research |z United States |v Congresses | |
| 650 | 4 | |a Neurotoxicology |x Research |z United States |v Congresses | |
| 650 | 4 | |a Substance-Related Disorders |x physiopathology | |
| 650 | 0 | 7 | |a Halluzinogen |0 (DE-588)4134941-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Toxizitätstest |0 (DE-588)4060540-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Neurotoxizität |0 (DE-588)4123836-9 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Halluzinogen |0 (DE-588)4134941-6 |D s |
| 689 | 0 | 1 | |a Neurotoxizität |0 (DE-588)4123836-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Halluzinogen |0 (DE-588)4134941-6 |D s |
| 689 | 1 | 1 | |a Neurotoxizität |0 (DE-588)4123836-9 |D s |
| 689 | 1 | 2 | |a Toxizitätstest |0 (DE-588)4060540-1 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Erinoff, Lynda |e Sonstige |4 oth | |
| 830 | 0 | |a National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |v 136 |w (DE-604)BV001902214 |9 136 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006050030&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006050030 | ||
Datensatz im Suchindex
| _version_ | 1804123543340843008 |
|---|---|
| adam_text | ASSESSING NEUROTOXICITY OF DRUGS OF ABUSE EDITOR: LYNDA ERINOFF, PH.D.
NIDA RESEARCH MONOGRAPH 136 1993 U.S. DEPARTMENT OF HEALTH AND HUMAN
SERVICES PUBLIC HEALTH SERVICE NATIONAL INSTITUTES OF HEALTH NATIONAL
INSTITUTE ON DRUG ABUSE 5600 FISHERS LANE ROCKVILLE, MD 20857 V CONTENTS
PAGE PREFACE V LYNDA ERINOFF NEUROBEHAVIORAL METHODS USED IN
NEUROTOXICOLOGY 1 HUGH A. TILSON BEHAVIORAL CONSEQUENCES OF PARTIAL
MONOAMINE DEPLETION IN THE CNS AFTER METHAMPHETAMINE-LIKE DRUGS: THE
CONFLICT BETWEEN PHARMACOLOGY AND TOXICOLOGY 34 LEWIS S. SEIDEN, WILLIAM
L WOOLVERTON, STANLEY A. LORENS, JOSEPH E.G. WILLIAMS, REBECCA L CORWIN,
NORIO HATA, MARY OLIMSKI STRATEGIES FOR DETECTING SUBCLINICAL MONOAMINE
DEPLETIONS IN HUMANS .. 53 UNA D. MCCANN AND GEORGE A. RICAURTE SENSORY
EVOKED POTENTIALS: MEASURES OF NEUROTOXICITY 63 WILLIAM K. BOYES SILVER
STAINING AS A TOOL FOR NEUROTOXIC ASSESSMENT 101 CARLOS A. BELTRAMINO,
JOS6 DE OLMOS, FERENC GALLYAS, LENNART HEIMER, AND LASZLD ZABORSZKY
MAPPING TOXICANT-INDUCED NERVOUS SYSTEM DAMAGE WITH A CUPRIC SILVER
STAIN: A QUANTITATIVE ANALYSIS OF NEURAL DEGENERATION INDUCED BY
3,4-METHYLENEDIOXYMETHAMPHETAMINE 133 KARL F. JENSEN, JEANENE OLIN,
NAJWA HAYKAL-COATES, JAMES O CALLAGHAN, DIANE B. MILLER, AND JOSE S. DE
OLMOS IN REACTIONS OF 5-HT NEURONS TO DRUGS OF ABUSE: NEUROTOXICITY AND
PLASTICITY 155 MARY ANN WILSON, LAURA A. MAMOUNAS, KENNETH H. FASMAN,
KAREN J. AXT, AND MARK E. MOLLIVER QUANTIFICATION OF REACTIVE GLIOSIS AS
AN APPROACH TO NEUROTOXICITY ASSESSMENT 188 JAMES P. O CALLAGHAN AND
DIANE B. MILLER PHARMACOKINETIC APPROACHES TO THE STUDY OF DRUG ACTION
AND TOXICITY 213 ARTHUR K. CHO, MASAYUKI HIRAMATSU, YOSHITO KUMAGAL, AND
NITA PATEL MECHANISMS MEDIATING BIOGENIC AMINE DEFICITS INDUCED BY
AMPHETAMINE AND ITS CONGENERS 226 JAMES W. GIBB, MICHEL JOHNSON, DONNA
M. STONE, AND GLEN R. HANSON NEUROTOXICITY AND DRUGS OF ABUSE:
CANNABINOID INTERACTION WITH BRAIN GLUCOCORTICOID RECEPTORS 242 PHILIP
W. LANDFIELD AND J. CHARLES ELDRIDGE NITRIC OXIDE AS A MEDIATOR OF
NEUROTOXICITY 253 TED M. DAWSON, VALINA L. DAWSON, AND SOLOMON H. SNYDER
LIST OF NIDA RESEARCH MONOGRAPHS 274 IV
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV009127565 |
| callnumber-first | R - Medicine |
| callnumber-label | RC347 |
| callnumber-raw | RC347.5 RM316 |
| callnumber-search | RC347.5 RM316 |
| callnumber-sort | RC 3347.5 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)29307989 (DE-599)BVBBV009127565 |
| dewey-full | 615/.78 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.78 |
| dewey-search | 615/.78 |
| dewey-sort | 3615 278 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02222nam a2200529 cb4500</leader><controlfield tag="001">BV009127565</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">940314s1993 d||| |||| 00||| engod</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)29307989</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009127565</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC347.5</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM316</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.78</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Assessing neurotoxicity of drugs of abuse</subfield><subfield code="c">ed.: Lynda Erinoff</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rockville, MD</subfield><subfield code="b">National Inst. on Drug Abuse</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VI, 281 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series</subfield><subfield code="v">136</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Central Nervous System Agents</subfield><subfield code="x">toxicity</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Central Nervous System</subfield><subfield code="x">drug effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug abuse</subfield><subfield code="x">Health aspects</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neuropharmacology</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurotoxicology</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance-Related Disorders</subfield><subfield code="x">physiopathology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Toxizitätstest</subfield><subfield code="0">(DE-588)4060540-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Neurotoxizität</subfield><subfield code="0">(DE-588)4123836-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Neurotoxizität</subfield><subfield code="0">(DE-588)4123836-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Neurotoxizität</subfield><subfield code="0">(DE-588)4123836-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Toxizitätstest</subfield><subfield code="0">(DE-588)4060540-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Erinoff, Lynda</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series</subfield><subfield code="v">136</subfield><subfield code="w">(DE-604)BV001902214</subfield><subfield code="9">136</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006050030&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006050030</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV009127565 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:31:26Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006050030 |
| oclc_num | 29307989 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | VI, 281 S. graph. Darst. |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | National Inst. on Drug Abuse |
| record_format | marc |
| series | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |
| series2 | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |
| spelling | Assessing neurotoxicity of drugs of abuse ed.: Lynda Erinoff Rockville, MD National Inst. on Drug Abuse 1993 VI, 281 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series 136 Central Nervous System Agents toxicity Central Nervous System drug effects Drug abuse Health aspects Research United States Congresses Neuropharmacology Research United States Congresses Neurotoxicology Research United States Congresses Substance-Related Disorders physiopathology Halluzinogen (DE-588)4134941-6 gnd rswk-swf Toxizitätstest (DE-588)4060540-1 gnd rswk-swf Neurotoxizität (DE-588)4123836-9 gnd rswk-swf USA (DE-588)1071861417 Konferenzschrift gnd-content Halluzinogen (DE-588)4134941-6 s Neurotoxizität (DE-588)4123836-9 s DE-604 Toxizitätstest (DE-588)4060540-1 s Erinoff, Lynda Sonstige oth National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series 136 (DE-604)BV001902214 136 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006050030&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Assessing neurotoxicity of drugs of abuse National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series Central Nervous System Agents toxicity Central Nervous System drug effects Drug abuse Health aspects Research United States Congresses Neuropharmacology Research United States Congresses Neurotoxicology Research United States Congresses Substance-Related Disorders physiopathology Halluzinogen (DE-588)4134941-6 gnd Toxizitätstest (DE-588)4060540-1 gnd Neurotoxizität (DE-588)4123836-9 gnd |
| subject_GND | (DE-588)4134941-6 (DE-588)4060540-1 (DE-588)4123836-9 (DE-588)1071861417 |
| title | Assessing neurotoxicity of drugs of abuse |
| title_auth | Assessing neurotoxicity of drugs of abuse |
| title_exact_search | Assessing neurotoxicity of drugs of abuse |
| title_full | Assessing neurotoxicity of drugs of abuse ed.: Lynda Erinoff |
| title_fullStr | Assessing neurotoxicity of drugs of abuse ed.: Lynda Erinoff |
| title_full_unstemmed | Assessing neurotoxicity of drugs of abuse ed.: Lynda Erinoff |
| title_short | Assessing neurotoxicity of drugs of abuse |
| title_sort | assessing neurotoxicity of drugs of abuse |
| topic | Central Nervous System Agents toxicity Central Nervous System drug effects Drug abuse Health aspects Research United States Congresses Neuropharmacology Research United States Congresses Neurotoxicology Research United States Congresses Substance-Related Disorders physiopathology Halluzinogen (DE-588)4134941-6 gnd Toxizitätstest (DE-588)4060540-1 gnd Neurotoxizität (DE-588)4123836-9 gnd |
| topic_facet | Central Nervous System Agents toxicity Central Nervous System drug effects Drug abuse Health aspects Research United States Congresses Neuropharmacology Research United States Congresses Neurotoxicology Research United States Congresses Substance-Related Disorders physiopathology Halluzinogen Toxizitätstest Neurotoxizität USA Konferenzschrift |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006050030&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV001902214 |
| work_keys_str_mv | AT erinofflynda assessingneurotoxicityofdrugsofabuse |